molecular pathology tests: choosing among the many
DESCRIPTION
Molecular Pathology Tests: Choosing Among the Many. Jennifer Laudadio, MD University of Arkansas for Medical Sciences. Disclosures. None. Objectives. Assess appropriateness of molecular testing requests and decide among the available methods - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/1.jpg)
Molecular Pathology Tests:Choosing Among the Many
Jennifer Laudadio, MDUniversity of Arkansas for Medical Sciences
![Page 2: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/2.jpg)
Disclosures
• None
![Page 3: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/3.jpg)
Objectives
• Assess appropriateness of molecular testing requests and decide among the available methods
• Evaluate quality and cost-effectiveness of testing options when deciding which ones to bring in-house
![Page 4: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/4.jpg)
THE 3PM PHONE CALL
(OR EMAIL)
![Page 5: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/5.jpg)
What Now?
• The test you know absolutely nothing about• The test you know about but don’t know if the
methodology matters and don’t know where to send it
• The test you know all about but don’t know where to send it
• The test request you know how to handle – EASY, DONE
![Page 6: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/6.jpg)
The test you know nothing about
• Spend a couple of hours researching the test• Knock on your colleagues door• Ask your colleague requesting the test to send
you information• Check reference lab test menus• Check www.amp.org test menu
![Page 7: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/7.jpg)
The test you know nothing about
• Is this medically necessary?• What is the cost?• Has the requesting doctor talked to the
patient about this super expensive test?• Do multiple labs offer the test?• Do all labs use the same test method?
![Page 8: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/8.jpg)
Example
“That test that tells me where the primary tumor is”
![Page 9: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/9.jpg)
What tests are available?
• Biotheranostics• Pathwork Diagnostics• Rosetta Genomics
![Page 10: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/10.jpg)
Biotheranostics• CancerType ID• Laser micro-dissection (need special slides)• Real Time RT-PCR• 92 genes
87 tumor associated5 reference
• Classifies 50 cancer types/subtypes87% accurate for 28 main tumor types82% accurate for 50 subtypes
![Page 11: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/11.jpg)
Pathwork Diagnostics• Tissue of Origin Test• DNA based expression array• ~2000 genes• Classifies 15 primary types/ 58 morphologies• 89% positive agreement• FDA-cleared for formalin fixed paraffin
embedded tissue
![Page 12: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/12.jpg)
Rosetta Genomics• miRview Mets 2• Expression levels of micro-RNAs• 64 micro-RNAs• Classifies 42 tumor types• 85% sensitivity
![Page 13: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/13.jpg)
What tissue is available for testing?What are the specimen requirements for
each test?
• Specimen size?• Tumor cellularity?• Decalcified?
• Test methodology can impact what sample is acceptable.
![Page 14: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/14.jpg)
Is each test equally “good”?
• Monzon FA and Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med. 2010; 134(2):216-224.
![Page 15: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/15.jpg)
Shipping Requirements?
Don’t forget about the $$!
• Does the company direct patient/insurance bill?
• What is the cost of the test?• Has the oncologist discussed this test with the
patient?
![Page 16: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/16.jpg)
The test you know nothing about
• Yes, there will be preliminary information gathering necessary– Ask the requesting oncologist for information– Ask your colleagues if they have had any
experience with any of the tests and what they thought
• Yes, the second time you get this request, it will go much smoother
![Page 17: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/17.jpg)
The test you have heard about
• Method?– Probably the hardest part– Intro to molecular methods CME– Webinars
• Which reference lab?• Specimen requirements?– Test the primary or metastasis?
![Page 18: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/18.jpg)
Example
KRAS mutation testing for metastatic colorectal carcinoma
![Page 19: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/19.jpg)
Methodology
• Sensitivity• Specific codons targeted by the method• Examples of methods used for KRAS testing– Sequencing– Pyrosequencing– Allele specific PCR
![Page 20: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/20.jpg)
KRAS Methodology• Sequencing
– Get information on entire exon– Need at least 20% mutant allele – Does lab inhibit wild type alleles to increase sensitivity?
• Pyrosequencing– Improves sensitivity– Targets specific mutations– Special instrumentation
• Allele specific PCR– Targets specific codon 12 and 13 point mutations– Sensitivity down to ~1% mutant allele– Is it too sensitive?
![Page 21: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/21.jpg)
Specimen Requirements and Selecting a Reference Lab
• FFPE acceptable– Block– Unstained slides (don’t have to be charged)
• Test either the metastasis or primary • The usual reference lab– all our reference testing has to go to lab X
• Search for a reference lab– Google reference lab test menus
• Mayo Test Menu– Get info on methodology, specimen requirements, clinical
utility, access requisition form, etc
![Page 22: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/22.jpg)
Scenarios have been reactiveWhat about being proactive?
![Page 23: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/23.jpg)
Proactive
• You make that phone call to recommend a test• Reflex testing policy
![Page 24: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/24.jpg)
You recommend a test
You diagnose metastatic colorectal carcinoma in a liver biopsy – call surgeon or oncologist and ask if they want it sent for KRAS testing.
![Page 25: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/25.jpg)
Reflex Testing
HPV for oropharyngeal squamous cell carcinomas
![Page 26: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/26.jpg)
Establishing a Reflex Testing Policy• Communication– Requests from clinicians– Agreement among Pathologists
• Methodology• How to get a reflex testing policy approved?– Medical Center Dependent– How to communicate the new policy once approved
• Monitor adherence
![Page 27: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/27.jpg)
Specifics from experience with HPV
• Multi-disciplinary requestsENT surgeonsMedical oncologistRadiation oncologist
• IndicationsPrognostic and PredictiveDiagnostic
![Page 28: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/28.jpg)
Specifics from experience with HPV• Choosing a Methodology– In situ hybridization
• High specificity• Low sensitivity
– PCR• High sensitivity• Is it too sensitive?
– P16• Surrogate• High sensitivity• Lower specificity
In situhybridization
p16 IHC
![Page 29: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/29.jpg)
Specifics from experience with HPV
• Drafting a Reflex Policy– Specific Diagnoses that would trigger the reflex
test– CPT codes
• Getting the Policy Approved• Communicating the Policy
![Page 30: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/30.jpg)
You want to get into the Molecular Diagnostics Game
What tests to bring in house?
![Page 31: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/31.jpg)
Test VolumesIf you build it, will they come?
Cost savings?
![Page 32: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/32.jpg)
Type of equipment and expertise needed?
• FDA approved testsRequire less expertiseExpenseVerification of performance characteristics
• Lab Developed testsTime for developmentExpertiseMore rigorous validation
![Page 33: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/33.jpg)
What’s Realistic
• Dedicated Research/Development personOne test a month
• Pathologists also involved in patient care3-4 tests per year
• Don’t forget the need for IT support!!
![Page 34: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/34.jpg)
Will I get paid?
• New CPT codesBased on analyte being testedNot method specificReplace “stacking” codesOn clinical lab fee scheduleG code for professional interpretation
• Gap-fill method of determining reimbursement• Critical time to work with payers
![Page 35: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/35.jpg)
Take Home Points
• Yes, it can be taxing to your practice to evaluate molecular testing requests.
• You can handle these requests either proactively or reactively
• Reactive is not necessarily bad• Take advantage of the resources around you –
the requesting MD, other pathologists, On-line test menus, Google, webinars, CME
![Page 36: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/36.jpg)
Take Home Points: Examples of Tests• Tests for tumor of unknown origin– Medical necessity– Methodology and Targeted genes– Specimen Requirements
• KRAS– Methodology and Mutation targets– Finding a reference lab– Mets versus Primary
• HPV– Developing a reflex testing policy– Selecting a method
![Page 37: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/37.jpg)
Take Home Points
• A basic understanding of molecular techniques may prove useful
• Deciding to bring tests in-house– FDA-approved versus lab developed– Performance Characteristics– Cost– Expertise necessary
![Page 38: Molecular Pathology Tests: Choosing Among the Many](https://reader036.vdocument.in/reader036/viewer/2022062323/568166b4550346895ddab9f4/html5/thumbnails/38.jpg)
Thank You